Lineage Cell Therapeutics Inc
Statements
Balance Sheet
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | 1996 | 1997 | 1998 | 1999 | 2000 | 2001 | 2002 | 2003 | 2004 | 2005 | 2006 | 2007 | 2008 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | +176.7% | -66.3% | +102.8% | -70.5% | +15.7% | -22.9% | -28.4% | +42.0% | +28.7% | -66.8% | -73.1% | +491.3% | +1,197.3% | +296.6% | -14.0% | -35.1% | +94.1% | +29.7% | +26.4% | +50.6% | +21.5% | -41.3% | +23.4% | -14.0% | +61.7% | -29.2% | -18.3% | +12.1% | -0.6% | |
| – | +182.8% | -68.3% | +107.7% | -73.3% | +22.3% | -21.6% | -27.1% | +48.3% | +29.4% | -68.0% | -77.1% | -23.1% | +11,258.1% | +187.7% | -29.8% | -71.2% | +10.7% | +307.6% | +45.8% | -45.7% | +66.2% | -14.7% | +58.2% | -23.5% | +153.5% | -46.2% | -35.9% | +32.7% | +16.0% | |
| – | +225.0% | -69.2% | +120.5% | -75.1% | +25.4% | -22.3% | -44.2% | +91.1% | +33.8% | -69.4% | -98.3% | +29.2% | +99,167.7% | +173.4% | -33.3% | -80.4% | +26.3% | +436.6% | +43.2% | -47.7% | +66.8% | -36.0% | -59.7% | +243.1% | +71.1% | -79.6% | +212.1% | +29.2% | -10.9% | |
| – | +225.0% | -69.2% | +120.5% | -75.1% | +25.4% | -22.3% | -44.2% | +91.1% | +33.8% | -69.4% | -98.3% | +29.2% | +99,167.7% | +173.4% | -33.3% | -80.4% | +26.3% | +436.6% | +45.8% | -47.2% | +68.1% | -19.5% | -0.1% | +35.3% | +40.4% | -0.8% | -38.7% | +34.7% | +16.7% | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | -6.6% | +57.9% | -29.7% | +163.3% | +22.1% | +565.2% | -100.0% | +1,278,400.0% | -99.4% | +150.8% | -14.4% | +144.8% | |
| – | -50.0% | +0.0% | – | – | – | – | – | – | – | – | – | – | – | +18.5% | +12.5% | +8.1% | +223.0% | +48.9% | -99.6% | – | – | +0.0% | +0.0% | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | -4.7% | +163.8% | -26.7% | +0.1% | +5.5% | +40.1% | -31.1% | -13.5% | +16.4% | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | +0.0% | +0.0% | +0.0% | +0.0% | +0.0% | +0.0% | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | +21.0% | +10.0% | +125.6% | -15.9% | -13.5% | -69.6% | -32.4% | -54.7% | +1,443.9% | -2.5% | -0.4% | -0.3% | -0.3% | 0.0% | -31.9% | |
| – | +800.0% | -77.8% | +48.9% | -39.6% | +467.2% | +30.7% | +31.3% | -66.4% | +83.2% | +16.7% | +28.1% | +67.1% | -55.7% | +61.2% | +13.6% | +24.8% | +183.6% | -21.3% | +49.6% | -33.8% | -25.6% | +4.9% | +51.2% | -9.9% | +552.4% | -38.2% | -24.6% | -7.2% | +91.2% | |
| – | +1,200.0% | -69.2% | +48.9% | -39.6% | -14.0% | +61.1% | +520.8% | -91.1% | +156.7% | -12.9% | +136.8% | +131.7% | -65.6% | +113.4% | +26.9% | +39.5% | +58.5% | +2.5% | +74.8% | -29.0% | -22.3% | -1.0% | -4.7% | +19.6% | +506.5% | -59.7% | -5.4% | -22.2% | -18.7% | |
| – | – | – | – | – | – | – | – | – | – | -23.8% | +66.0% | +163.2% | – | – | – | – | – | – | -24.3% | +752.6% | -67.9% | -15.7% | +298.4% | +5.1% | -35.3% | +14.6% | -7.4% | +30.6% | -26.0% | |
| – | +0.0% | +0.0% | +197.8% | -39.6% | -14.0% | +15.7% | +14.2% | -32.7% | +105.8% | -23.8% | +11.3% | – | – | – | – | +256.8% | -13.9% | -33.1% | +21.8% | -43.1% | -41.1% | +151.5% | +2.9% | +7.6% | +35.7% | -32.5% | -14.3% | -42.7% | +99.4% | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | +1,114.4% | -76.8% | -98.4% | – | – | – | – | – | – | – | – | |
| – | +132.1% | -63.1% | +111.8% | -74.1% | -107.5% | – | – | – | -157.0% | – | – | – | – | +441.7% | -25.0% | -15.2% | -39.1% | +146.3% | -26.2% | +338.5% | +37.9% | -42.3% | +20.4% | -14.8% | -4.1% | -20.5% | -13.5% | +23.6% | -43.2% | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | +6.5% | +12.7% | +6.9% | +3.3% | +4.7% | +7.0% | +15.3% | +22.4% | +2.6% | +25.9% | +1.4% | +3.9% | +23.4% | +37.4% | +16.9% | +4.6% | +10.2% | +22.6% | +19.9% | +24.9% | +15.0% | +10.9% | +14.7% | +3.1% | +9.6% | +3.2% | +1.7% | +15.9% | +14.9% |
Data as of: October 5, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.